Form 13F-HR AIGH Capital Management For: Jun 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
August 12, 2022 10:27 AM EDT
The Securities and Exchange Commission has not necessarily reviewed
the information in this filing and has not determined if it is
accurate and complete.
The reader should not assume that the information is accurate
and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F
FORM 13F COVER PAGE
|
| OMB APPROVAL |
| OMB Number: |
3235-0006 |
| Expires: |
July 31, 2015 |
| Estimated average burden |
| hours per response: |
23.8 |
|
|
| Report for the Calendar Year or Quarter Ended: |
06-30-2022 |
| Check here if Amendment |
|
Amendment Number: |
|
| This Amendment (Check only one.): |
|
is a restatement. |
|
|
adds new holdings entries. |
| Institutional Investment Manager Filing
this Report: |
| Name: |
AIGH Capital Management LLC |
| Address: |
6006 BERKELEY AVE. |
|
|
|
BALTIMORE
,
MD21209
|
| Form 13F File Number: |
028-20823 |
The institutional investment manager filing this report and
the person by whom it is signed hereby represent that the person
signing the report is authorized to submit it, that all information
contained herein is true, correct and complete, and that it is
understood that all required items, statements, schedules, lists, and
tables, are considered integral parts of this form.
| Person Signing this Report on Behalf of
Reporting Manager: |
| Name: |
Orin Hirschman |
| Title: |
Managing Member |
| Phone: |
410-415-6464 |
| Signature, Place, and Date of Signing: |
| /s/ Orin Hirschman |
Baltimore
,
MD
|
08-11-2022 |
| [Signature] |
[City, State] |
[Date] |
|
| Report Type (Check only one.): |
| X |
13F HOLDINGS REPORT. (Check here if all holdings of
this reporting manager are reported in this report.) |
|
|
13F NOTICE. (Check here if no holdings reported are in
this report, and all holdings are reported by other reporting
manager(s).) |
|
|
13F COMBINATION REPORT. (Check here if a portion of
the holdings for this reporting manager are reported in this
report and a portion are reported by other reporting manager(s).) |
| Form 13F Summary Page |
|
Report Summary: |
|
Number of Other Included
Managers: |
1 |
|
|
|
Form 13F Information Table Entry Total: |
94 |
|
Form 13F Information Table Value Total: |
380,049 |
|
(thousands) |
|
List of Other Managers Reporting for this Manager:
[If there are no entries in this list, omit this section.]
|
|
|
Form 13F File Number |
Name |
|
028-17947 |
Worth Venture Partners, LLC |
| List of Other Included
Managers: |
|
Provide a numbered list of the name(s) and Form 13F file number(s)
of all institutional investment managers with respect to which this
report is filed, other than the
manager filing this report.
|
|
[If there are no entries in this list, state “NONE” and omit the
column headings and list entries.]
|
|
No. |
Form 13F File Number |
Name |
|
1 |
028-17947 |
Worth Venture Partners, LLC |
The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
The reader should not assume that the information is
accurate and complete.
|
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F
FORM 13F INFORMATION TABLE
|
| OMB APPROVAL |
| OMB Number: |
3235-0006 |
| Expires: |
July 31, 2015 |
| Estimated average
burden |
| hours per response:
|
23.8 |
|
|
| COLUMN 1 |
COLUMN 2 |
COLUMN 3 |
COLUMN 4 |
COLUMN 5 |
COLUMN 6 |
COLUMN 7 |
COLUMN 8 |
|
|
|
VALUE |
SHRS OR |
SH/ |
PUT/ |
INVESTMENT |
OTHER |
VOTING AUTHORITY |
| NAME OF ISSUER |
TITLE OF CLASS |
CUSIP |
(x$1000) |
PRN AMT |
PRN |
CALL |
DISCRETION |
MANAGER |
SOLE |
SHARED |
NONE |
| ADTRAN INC |
COM |
00738A106 |
15,265 |
870,778 |
SH |
|
SOLE |
|
870,778 |
0 |
0 |
| ADTRAN INC |
COM |
00738A106 |
5,088 |
290,241 |
SH |
|
OTR |
1 |
0 |
290,241 |
0 |
| AIRGAIN INC |
COM |
00938A104 |
4,443 |
547,176 |
SH |
|
SOLE |
|
547,176 |
0 |
0 |
| AIRGAIN INC |
COM |
00938A104 |
1,464 |
180,308 |
SH |
|
OTR |
1 |
0 |
180,308 |
0 |
| ANI PHARMACEUTICALS INC |
COM |
00182C103 |
5,449 |
183,669 |
SH |
|
SOLE |
|
183,669 |
0 |
0 |
| ANI PHARMACEUTICALS INC |
COM |
00182C103 |
1,805 |
60,831 |
SH |
|
OTR |
1 |
0 |
60,831 |
0 |
| ARDELYX INC |
COM |
039697107 |
1,676 |
2,841,472 |
SH |
|
SOLE |
|
2,841,472 |
0 |
0 |
| ARDELYX INC |
COM |
039697107 |
550 |
931,949 |
SH |
|
OTR |
1 |
0 |
931,949 |
0 |
| AVEO PHARMACEUTICALS INC |
COM NEW |
053588307 |
4,834 |
736,859 |
SH |
|
OTR |
1 |
0 |
736,859 |
0 |
| AVEO PHARMACEUTICALS INC |
COM NEW |
053588307 |
14,502 |
2,210,735 |
SH |
|
SOLE |
|
2,210,735 |
0 |
0 |
| AVIAT NETWORKS INC |
COM NEW |
05366Y201 |
7,650 |
305,508 |
SH |
|
SOLE |
|
305,508 |
0 |
0 |
| AVIAT NETWORKS INC |
COM NEW |
05366Y201 |
2,564 |
102,410 |
SH |
|
OTR |
1 |
0 |
102,410 |
0 |
| BABCOCK & WILCOX ENTERPRISES |
COM |
05614L209 |
739 |
122,596 |
SH |
|
SOLE |
|
122,596 |
0 |
0 |
| BABCOCK & WILCOX ENTERPRISES |
COM |
05614L209 |
245 |
40,603 |
SH |
|
OTR |
1 |
0 |
40,603 |
0 |
| BK TECHNOLOGIES CORPORATION |
COM |
05587G104 |
915 |
345,434 |
SH |
|
OTR |
1 |
0 |
345,434 |
0 |
| BK TECHNOLOGIES CORPORATION |
COM |
05587G104 |
2,725 |
1,028,316 |
SH |
|
SOLE |
|
1,028,316 |
0 |
0 |
| BRIDGELINE DIGITAL INC |
COM |
10807Q700 |
52 |
43,154 |
SH |
|
OTR |
1 |
0 |
43,154 |
0 |
| BRIDGELINE DIGITAL INC |
COM |
10807Q700 |
162 |
134,849 |
SH |
|
SOLE |
|
134,849 |
0 |
0 |
| CALAMP CORP |
COM |
128126109 |
2,423 |
581,045 |
SH |
|
OTR |
1 |
0 |
581,045 |
0 |
| CALAMP CORP |
COM |
128126109 |
7,322 |
1,755,897 |
SH |
|
SOLE |
|
1,755,897 |
0 |
0 |
| CELLECTAR BIOSCIENCES INC |
COM PAR |
15117F500 |
1,440 |
1,378,801 |
SH |
|
SOLE |
|
1,378,801 |
0 |
0 |
| CELLECTAR BIOSCIENCES INC |
COM PAR |
15117F500 |
185 |
458,245 |
SH |
|
OTR |
1 |
0 |
458,245 |
0 |
| COGNITION THERAPEUTICS INC |
COM |
19243B102 |
1,896 |
682,620 |
SH |
|
SOLE |
|
682,620 |
0 |
0 |
| COGNITION THERAPEUTICS INC |
COM |
19243B102 |
486 |
228,170 |
SH |
|
OTR |
1 |
0 |
228,170 |
0 |
| CONTEXT THERAPEUTICS INC |
COM |
21077P108 |
557 |
894,159 |
SH |
|
SOLE |
|
894,159 |
0 |
0 |
| CONTEXT THERAPEUTICS INC |
COM |
21077P108 |
631 |
297,612 |
SH |
|
OTR |
1 |
0 |
297,612 |
0 |
| CYBEROPTICS CORP |
COM |
232517102 |
13,363 |
382,451 |
SH |
|
SOLE |
|
382,451 |
0 |
0 |
| CYBEROPTICS CORP |
COM |
232517102 |
4,454 |
127,466 |
SH |
|
OTR |
1 |
0 |
127,466 |
0 |
| CYCLO THERAPEUTICS INC |
*W EXP 11/14/202 |
23254X110 |
37 |
74,236 |
SH |
Call |
OTR |
1 |
0 |
74,236 |
0 |
| CYCLO THERAPEUTICS INC |
*W EXP 11/14/202 |
23254X110 |
1 |
220,195 |
SH |
Call |
SOLE |
|
220,195 |
0 |
0 |
| DZS INC |
COM |
268211109 |
20,704 |
1,272,529 |
SH |
|
SOLE |
|
1,272,529 |
0 |
0 |
| DZS INC |
COM |
268211109 |
6,766 |
415,837 |
SH |
|
OTR |
1 |
0 |
415,837 |
0 |
| EVERSPIN TECHNOLOGIES INC |
COM |
30041T104 |
1,681 |
320,798 |
SH |
|
OTR |
1 |
0 |
320,798 |
0 |
| EVERSPIN TECHNOLOGIES INC |
COM |
30041T104 |
5,048 |
963,451 |
SH |
|
SOLE |
|
963,451 |
0 |
0 |
| EVOLUS INC |
COM |
30052C107 |
498 |
42,940 |
SH |
|
OTR |
1 |
0 |
42,940 |
0 |
| EVOLUS INC |
COM |
30052C107 |
1,504 |
129,652 |
SH |
|
SOLE |
|
129,652 |
0 |
0 |
| FRANKLIN WIRELESS CORP |
COM |
355184102 |
319 |
98,826 |
SH |
|
OTR |
1 |
0 |
98,826 |
0 |
| FRANKLIN WIRELESS CORP |
COM |
355184102 |
924 |
291,174 |
SH |
|
SOLE |
|
291,174 |
0 |
0 |
| ICAD INC |
COM NEW |
44934S206 |
1,385 |
346,183 |
SH |
|
OTR |
1 |
0 |
346,183 |
0 |
| ICAD INC |
COM NEW |
44934S206 |
4,057 |
1,014,327 |
SH |
|
SOLE |
|
1,014,327 |
0 |
0 |
| IDEAL PWR INC |
COM NEW |
451622203 |
647 |
52,888 |
SH |
|
OTR |
1 |
0 |
52,888 |
0 |
| IDEAL PWR INC |
COM NEW |
451622203 |
1,964 |
160,480 |
SH |
|
SOLE |
|
160,480 |
0 |
0 |
| ISHARES TR |
RUSSELL 2000 ETF |
464287655 |
104,343 |
616,100 |
SH |
Put |
SOLE |
|
616,100 |
0 |
0 |
| ISHARES TR |
RUSSELL 2000 ETF |
464287655 |
34,533 |
203,900 |
SH |
Put |
OTR |
1 |
0 |
203,900 |
0 |
| LIGHTPATH TECHNOLOGIES INC |
COM CL A |
532257805 |
1,882 |
1,530,407 |
SH |
|
SOLE |
|
1,530,407 |
0 |
0 |
| LIGHTPATH TECHNOLOGIES INC |
COM CL A |
532257805 |
627 |
509,425 |
SH |
|
OTR |
1 |
0 |
509,425 |
0 |
| MATERION CORP |
COM |
576690101 |
10,035 |
136,111 |
SH |
|
SOLE |
|
136,111 |
0 |
0 |
| MATERION CORP |
COM |
576690101 |
3,324 |
45,078 |
SH |
|
OTR |
1 |
0 |
45,078 |
0 |
| MEDICENNA THERAPEUTICS CORP |
COM |
58490H107 |
674 |
571,489 |
SH |
|
OTR |
1 |
0 |
571,489 |
0 |
| MEDICENNA THERAPEUTICS CORP |
COM |
58490H107 |
1,973 |
1,701,211 |
SH |
|
SOLE |
|
1,701,211 |
0 |
0 |
| MYOMO INC |
COM NEW |
62857J201 |
778 |
463,243 |
SH |
|
SOLE |
|
463,243 |
0 |
0 |
| MYOMO INC |
COM NEW |
62857J201 |
259 |
153,936 |
SH |
|
OTR |
1 |
0 |
153,936 |
0 |
| NEUBASE THERAPEUTICS INC |
COM |
64132K102 |
269 |
256,553 |
SH |
|
OTR |
1 |
0 |
256,553 |
0 |
| NEUBASE THERAPEUTICS INC |
COM |
64132K102 |
810 |
771,032 |
SH |
|
SOLE |
|
771,032 |
0 |
0 |
| NLS PHARMACEUTICS LTD |
*W EXP 09/25/202 |
H57830111 |
23 |
194,060 |
SH |
Call |
OTR |
1 |
0 |
194,060 |
0 |
| NLS PHARMACEUTICS LTD |
*W EXP 09/25/202 |
H57830111 |
76 |
633,361 |
SH |
Call |
SOLE |
|
633,361 |
0 |
0 |
| PARABELLUM ACQUISITION CORP |
*W EXP 99/99/999 |
69901P117 |
9 |
139,072 |
SH |
Call |
OTR |
1 |
0 |
139,072 |
0 |
| PARABELLUM ACQUISITION CORP |
*W EXP 99/99/999 |
69901P117 |
29 |
450,214 |
SH |
Call |
SOLE |
|
450,214 |
0 |
0 |
| PARATEK PHARMACEUTICALS INC |
COM |
699374302 |
1,631 |
845,298 |
SH |
|
OTR |
1 |
0 |
845,298 |
0 |
| PARATEK PHARMACEUTICALS INC |
COM |
699374302 |
4,906 |
2,541,874 |
SH |
|
SOLE |
|
2,541,874 |
0 |
0 |
| PROCESSA PHARMACEUTICALS INC |
COM NEW |
74275C205 |
654 |
232,749 |
SH |
|
SOLE |
|
232,749 |
0 |
0 |
| PROCESSA PHARMACEUTICALS INC |
COM NEW |
74275C205 |
199 |
70,954 |
SH |
|
OTR |
1 |
0 |
70,954 |
0 |
| REZOLUTE INC |
COM NEW |
76200L309 |
68 |
21,126 |
SH |
|
OTR |
1 |
0 |
21,126 |
0 |
| REZOLUTE INC |
COM NEW |
76200L309 |
206 |
63,657 |
SH |
|
SOLE |
|
63,657 |
0 |
0 |
| RF INDS LTD |
COM PAR $0.01 |
749552105 |
2,377 |
383,353 |
SH |
|
SOLE |
|
383,353 |
0 |
0 |
| RF INDS LTD |
COM PAR $0.01 |
749552105 |
798 |
128,684 |
SH |
|
OTR |
1 |
0 |
128,684 |
0 |
| RVL PHARMACEUTICALS PLC |
SHS |
G6S41R101 |
29 |
21,146 |
SH |
|
OTR |
1 |
0 |
21,146 |
0 |
| RVL PHARMACEUTICALS PLC |
SHS |
G6S41R101 |
87 |
63,847 |
SH |
|
SOLE |
|
63,847 |
0 |
0 |
| SAVERONE 2014 LTD |
SPONSORED ADS |
80516T105 |
708 |
307,237 |
SH |
|
SOLE |
|
307,237 |
0 |
0 |
| SAVERONE 2014 LTD |
SPONSORED ADS |
80516T105 |
50 |
141,864 |
SH |
Call |
OTR |
1 |
0 |
141,864 |
0 |
| SAVERONE 2014 LTD |
SPONSORED ADS |
80516T105 |
150 |
428,330 |
SH |
Call |
SOLE |
|
428,330 |
0 |
0 |
| SAVERONE 2014 LTD |
SPONSORED ADS |
80516T105 |
319 |
141,863 |
SH |
|
OTR |
1 |
0 |
141,863 |
0 |
| SCPHARMACEUTICALS INC |
COM |
810648105 |
4,872 |
1,010,739 |
SH |
|
SOLE |
|
1,010,739 |
0 |
0 |
| SCPHARMACEUTICALS INC |
COM |
810648105 |
1,619 |
335,985 |
SH |
|
OTR |
1 |
0 |
335,985 |
0 |
| SCYNEXIS INC |
COM NEW |
811292200 |
3,120 |
1,677,619 |
SH |
|
SOLE |
|
1,677,619 |
0 |
0 |
| SCYNEXIS INC |
COM NEW |
811292200 |
1,043 |
560,517 |
SH |
|
OTR |
1 |
0 |
560,517 |
0 |
| SILICON MOTION TECHNOLOGY CO |
SPONSORED ADR |
82706C108 |
7,162 |
85,565 |
SH |
|
SOLE |
|
85,565 |
0 |
0 |
| SILICON MOTION TECHNOLOGY CO |
SPONSORED ADR |
82706C108 |
2,413 |
28,835 |
SH |
|
OTR |
1 |
0 |
28,835 |
0 |
| SOLENO THERAPEUTICS INC |
COM NEW |
834203200 |
293 |
1,582,704 |
SH |
|
OTR |
1 |
0 |
1,582,704 |
0 |
| SOLENO THERAPEUTICS INC |
COM NEW |
834203200 |
884 |
4,778,645 |
SH |
|
SOLE |
|
4,778,645 |
0 |
0 |
| SONO GROUP N V |
COM |
N81409109 |
2,572 |
874,813 |
SH |
|
OTR |
1 |
0 |
874,813 |
0 |
| SONO GROUP N V |
COM |
N81409109 |
7,765 |
2,641,316 |
SH |
|
SOLE |
|
2,641,316 |
0 |
0 |
| TELA BIO INC |
COM |
872381108 |
1,614 |
230,296 |
SH |
|
SOLE |
|
230,296 |
0 |
0 |
| TELA BIO INC |
COM |
872381108 |
542 |
76,168 |
SH |
|
OTR |
1 |
0 |
76,168 |
0 |
| THERATECHNOLOGIES INC |
COM |
88338H100 |
4,922 |
2,169,644 |
SH |
|
SOLE |
|
2,169,644 |
0 |
0 |
| THERATECHNOLOGIES INC |
COM |
88338H100 |
2,085 |
743,423 |
SH |
|
OTR |
1 |
0 |
743,423 |
0 |
| TRANSCODE THERAPEUTICS INC |
COM |
89357L105 |
1,216 |
964,843 |
SH |
|
SOLE |
|
964,843 |
0 |
0 |
| TRANSCODE THERAPEUTICS INC |
COM |
89357L105 |
408 |
324,157 |
SH |
|
OTR |
1 |
0 |
324,157 |
0 |
| TRANSPHORM INC |
COM |
89386L100 |
10,645 |
2,861,640 |
SH |
|
SOLE |
|
2,861,640 |
0 |
0 |
| TRANSPHORM INC |
COM |
89386L100 |
3,418 |
917,297 |
SH |
|
OTR |
1 |
0 |
917,297 |
0 |
| VACCINEX INC |
COM |
918640103 |
1,700 |
1,574,006 |
SH |
|
SOLE |
|
1,574,006 |
0 |
0 |
| VACCINEX INC |
COM |
918640103 |
548 |
507,795 |
SH |
|
OTR |
1 |
0 |
507,795 |
0 |
| X4 PHARMACEUTICALS INC |
COM |
98420X103 |
721 |
747,575 |
SH |
|
SOLE |
|
747,575 |
0 |
0 |
| X4 PHARMACEUTICALS INC |
COM |
98420X103 |
241 |
250,144 |
SH |
|
OTR |
1 |
0 |
250,144 |
0 |
Tweet
Share
E-mail
